Tryptophan Prevents the Development of Non-Alcoholic Fatty Liver Disease

References

• Galvan-Martinez DH, Bosquez-Mendoza VM, Ruiz-Noa Y, Ibarra-Reynoso LDR, Barbosa-Sabanero G, Lazo-de-la-Vega-Monroy ML. Nutritional, pharmacological, and environmental programming of NAFLD in early life. Am J Physiol Gastrointest Liver Physiol. 2023;324(2):G99–G114. doi:10.1152/ajpgi.00168.2022
   PubMed Web of Science ®Google Scholar
• Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116–141. doi:10.1016/j.freeradbiomed.2020.02.025
   PubMed Web of Science ®Google Scholar
• Pérez-Carreras M, Del Hoyo P, Martín MA, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology. 2003;38(4):999–1007. doi:10.1053/jhep.2003.50398
   PubMed Web of Science ®Google Scholar
• Lee K, Haddad A, Osme A, et al. Hepatic mitochondrial defects in a nonalcoholic fatty liver disease mouse model are associated with increased degradation of oxidative phosphorylation subunits. Mol Cell Proteomics. 2018;17(12):2371–2386. doi:10.1074/mcp.RA118.000961
   PubMed Web of Science ®Google Scholar
• Golubeva JA, Sheptulina AF, Yafarova AA, Mamutova EM, Kiselev AR, Drapkina OM. Reduced quality of life in patients with non-alcoholic fatty liver disease may be associated with depression and fatigue. Healthcare. 2022;10(9):1699. doi:10.3390/healthcare10091699
   Web of Science ®Google Scholar
• Shea S, Lionis C, Kite C, et al. Non-alcoholic fatty liver disease (NAFLD) and potential links to depression, anxiety, and chronic stress. Biomedicines. 2021;9(11):1697. doi:10.3390/biomedicines9111697
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Colombo M, Cortez-Pinto H, et al. NAFLD - sounding the alarm on a silent epidemic. Nat Rev Gastroenterol Hepatol. 2020;17(7):377–379. doi:10.1038/s41575-020-0315-7
   PubMed Web of Science ®Google Scholar
• Rinaldi L, Pafundi PC, Galiero R, et al. Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review. Antioxidants. 2021;10:270. doi:10.3390/antiox10020270
   Web of Science ®Google Scholar
• Iqbal U, Perumpail BJ, Akhtar D, Kim D, Ahmed A. The epidemiology, risk profiling and diagnostic challenges of nonalcoholic fatty liver disease. Medicines. 2019;6(1):41. doi:10.3390/medicines6010041
   Google Scholar
• Schiavo L, Busetto L, Cesaretti M, Zelber-Sagi S, Deutsch L, Iannelli A. Nutritional issues in patients with obesity and cirrhosis. World J Gastroenterol. 2018;24(30):3330–3346. doi:10.3748/wjg.v24.i30.3330
   PubMed Web of Science ®Google Scholar
• Mantovani A, Dalbeni A. Treatments for NAFLD: state of art. Int J Mol Sci. 2021;22(5):2350. doi:10.3390/ijms22052350
   PubMed Web of Science ®Google Scholar
• Głuszyńska P, Lemancewicz D, Dzięcioł JB, Razak Hady H. Non-alcoholic fatty liver disease (NAFLD) and bariatric/metabolic surgery as its treatment option: a review. J Clin Med. 2021;10(24):5721. doi:10.3390/jcm10245721
   PubMed Web of Science ®Google Scholar
• Platten M, Nollen EAA, Röhrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18(5):379–401. doi:10.1038/s41573-019-0016-5
   PubMed Web of Science ®Google Scholar
• Shipelin VA, Trusov NV, Apryatin SA, et al. Effects of tyrosine and tryptophan in rats with diet-induced obesity. Int J Mol Sci. 2021;22:24–29. doi:10.3390/ijms22052429
   Google Scholar
• Chen J, Vitetta L, Henson JD, Hall S. Intestinal dysbiosis, the tryptophan pathway and nonalcoholic steatohepatitis. Int J Tryptophan Res. 2022;15:11786469211070533. doi:10.1177/11786469211070533
   Web of Science ®Google Scholar
• Sun P, Wang M, Liu YX, et al. High-fat diet-disturbed gut microbiota-colonocyte interactions contribute to dysregulating peripheral tryptophan-kynurenine metabolism. Microbiome. 2023;11(1):154. doi:10.1186/s40168-023-01606-x
   PubMed Web of Science ®Google Scholar
• Madella AM, Van Bergenhenegouwen J, Garssen J, Masereeuw R, Overbeek SA. Microbial-derived tryptophan catabolites, kidney disease and gut inflammation. Toxins. 2022;14(9):645. doi:10.3390/toxins14090645
   PubMed Web of Science ®Google Scholar
• Hezaveh K, Shinde RS, Klötgen A, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55(2):324–340.e8. doi:10.1016/j.immuni.2022.01.006
   PubMed Web of Science ®Google Scholar
• Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012;13(7):465–477. doi:10.1038/nrn3257
   PubMed Web of Science ®Google Scholar
• Cussotto S, Delgado I, Anesi A, et al. Tryptophan metabolic pathways are altered in obesity and are associated with systemic inflammation. Front Immunol. 2020;11:557. doi:10.3389/fimmu.2020.00557
   PubMed Web of Science ®Google Scholar
• Tanaka M, Szabó Á, Spekker E, Polyák H, Tóth F, Vécsei L. Mitochondrial impairment: a common motif in neuropsychiatric presentation? The link to the tryptophan-kynurenine metabolic system. Cells. 2022;11(16):2607. doi:10.3390/cells11162607
   PubMed Web of Science ®Google Scholar
• Celinski K, Konturek PC, Slomka M, et al. Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up. J Physiol Pharmacol. 2014;65(1):75–82.
   PubMed Web of Science ®Google Scholar
• Ritze Y, Bárdos G, Hubert A, Böhle M, Bischoff SC. Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice. Br J Nutr. 2014;112(1):1–7. doi:10.1017/S0007114514000440
   PubMed Web of Science ®Google Scholar
• Osawa Y, Kanamori H, Seki E, et al. L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin. J Biol Chem. 2011;286(40):34800–34808. doi:10.1074/jbc.M111.235473
   PubMed Web of Science ®Google Scholar
• Янко РВ, Зінченко АС, Чака ОГ, Левашов МІ. Спосіб моделювання аліментарного жирового гепатозу у лабораторних щурів. Патент України № 150511. 2022 лютого 23. [Yanko RV, Zinchenko AS, Chaka OG, Levashov MI. Method of modeling alimentary fatty liver disease in laboratory rats. Ukraine patent No. 150511. 2022 Feb 23]. Ukraine.
   Google Scholar
• Badawy AA, Bano S. Tryptophan metabolism in rat liver after administration of tryptophan, kynurenine metabolites, and kynureninase inhibitors. Int J Tryptophan Res. 2016;9:51–65. doi:10.4137/IJTR.S38190
   PubMedGoogle Scholar
• Ayinde TO, Olayaki LA, Ojulari LS, Oluwasola A. Hepatoprotective effect of tryptophan in carbontetrachloride-induced hepatotoxicity in male Wistar rats. Int J Basic Appl Physiol. 2021;10(2):25–30.
   Google Scholar
• Rehfeld A, Nylander M, Karnov K. Histological methods. In: Compendium of Histology. Cham: Springer; 2017. doi:10.1007/978-3-319-41873-5_2
   Google Scholar
• Mamontov I, Ivakhno I, Tamm T, Panasenko V, Padalko V, Zulfugarov I. Morphometric parameters of hepatocytes in experimental complete extrahepatic bile duct obstruction. ScienceRise. 2020;1(34):51–56. doi:10.15587/2519-4798.2020.193845
   Google Scholar
• Yanko RV, Chaka OG, Levashov MI. Influence of methionine on morphofunctional changes of rat liver parenchyma. Fiziol Zh. 2020;66(5):38–45. doi:10.15407/fz66.05.038
   Google Scholar
• Reitman S, Frankel S. The structure and function of subcellular components. Am J Clin Pathol. 1957;28:56. doi:10.1093/ajcp/28.1.56
   PubMed Web of Science ®Google Scholar
• Swanson MA. Phosphatases of liver. I. Glucose-6-phosphatase. J Biol Chem. 1950;184(2):647–659.
   PubMed Web of Science ®Google Scholar
• Singer TP, Kearney EB, Bernath P. Studies on succinic dehydrogenase. Isolation and properties of the dehydrogenase from beef heart. J Biol Chem. 1956;223:599–613. doi:10.1016/S0021-9258(18)65059-8
   PubMed Web of Science ®Google Scholar
• Sumbalova Z, Fontana M, Krumschnabel G. Isolation of rat liver mitochondria. Mitochondr Physiol Network. 2016;20(08(02)):1–2.
   Google Scholar
• Chance B, Williams G. Respiratory enzymes in oxidative phosphorylation. The steady state. J Biol Chem. 1955;217:409–427. doi:10.1016/S0021-9258(19)57191-5
   PubMed Web of Science ®Google Scholar
• Shchelykalina SP, Nikolaev DV, Kolesnikov VA, Korostylev KA, Starunova OA. Technology of two-dimensional bioimpedance analysis of the human body composition. J Electr Bioimpedance. 2021;12(1):17–25. doi:10.2478/joeb-2021-0004
   PubMedGoogle Scholar
• Khalil SF, Mohktar MS, Ibrahim F. The theory and fundamentals of bioimpedance analysis in clinical status monitoring and diagnosis of diseases. Sensors. 2014;14(6):10895–10928. doi:10.3390/s140610895
   PubMed Web of Science ®Google Scholar
• Hanna DJ, Jamieson ST, Lee CS, et al. Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD. Obes Sci Pract. 2021;7(5):629–645. doi:10.1002/osp4.509
   PubMed Web of Science ®Google Scholar
• Karschau J, Scholich A, Wise J, et al. Resilience of three-dimensional sinusoidal networks in liver tissue. PLoS Comput Biol. 2020;16(6):e1007965. doi:10.1371/journal.pcbi.1007965
   PubMed Web of Science ®Google Scholar
• Dubois ML, Boisvert FM. The nucleolus: structure and function. Funct Nucleus. 2016;23:29–49. doi:10.1007/978-3-319-38882-3_2
   Google Scholar
• Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology. 2014;147(4):765–783.e4. doi:10.1053/j.gastro.2014.07.018
   PubMed Web of Science ®Google Scholar
• Wang W, Liu L, Tian Z, Han T, Sun C, Li Y. Dietary tryptophan and the risk of metabolic syndrome: total effect and mediation effect of sleep duration. Nat Sci Sleep. 2021;13:2141–2151. doi:10.2147/NSS.S337171
   PubMed Web of Science ®Google Scholar
• Lian CY, Zhai ZZ, Li ZF, Wang L. High fat diet-triggered non-alcoholic fatty liver disease: a review of proposed mechanisms. Chem Biol Interact. 2020;330:109199. doi:10.1016/j.cbi.2020.109199
   PubMed Web of Science ®Google Scholar
• Akiba Y, Takahashi K, Horiguchi M, Ohtani H, Saitoh S, Ohkawara H. L-Tryptophan alleviates fatty liver and modifies hepatic microsomal mixed function oxidase in laying hens. Comp Biochem Physiol Comp Physiol. 1992;102(4):769–774. doi:10.1016/0300-9629(92)90738-c
   PubMedGoogle Scholar
• Mangge H, Summers KL, Meinitzer A, et al. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome. Obesity. 2014;22(1):195–201. doi:10.1002/oby.20491
   PubMed Web of Science ®Google Scholar
• van Galen KA, Ter Horst KW, Serlie MJ. Serotonin, food intake, and obesity. Obes Rev. 2021;22(7):e13210. doi:10.1111/obr.13210
   PubMed Web of Science ®Google Scholar
• Sumara G, Sumara O, Kim JK, Karsenty G. Gut-derived serotonin is a multifunctional determinant to fasting adaptation. Cell Metab. 2012;16(5):588–600. doi:10.1016/j.cmet.2012.09.014
   PubMed Web of Science ®Google Scholar
• Guan Q, Wang Z, Cao J, Dong Y, Chen Y. Mechanisms of melatonin in obesity: a review. Int J Mol Sci. 2021;23(1):218. doi:10.3390/ijms23010218
   PubMed Web of Science ®Google Scholar
• Ou TH, Tung YT, Yang TH, Chien YW. Melatonin improves fatty liver syndrome by inhibiting the lipogenesis pathway in hamsters with high-fat diet-induced hyperlipidemia. Nutrients. 2019;11:748. doi:10.3390/nu11040748
   PubMed Web of Science ®Google Scholar
• Sato K, Meng F, Francis H, et al. Melatonin and circadian rhythms in liver diseases: functional roles and potential therapies. J Pineal Res. 2020;68:e12639. doi:10.1111/jpi.12639
   PubMed Web of Science ®Google Scholar
• Zhou H, Du W, Li Y, et al. Effects of melatonin on fatty liver disease: the role of NR4A1/DNA-PKcs/p53 pathway, mitochondrial fission, and mitophagy. J Pineal Res. 2018:64. doi:10.1111/jpi.12450
   Web of Science ®Google Scholar
• Watanabe H, Akasaka D, Ogasawara H, et al. Peripheral serotonin enhances lipid metabolism by accelerating bile acid turnover. Endocrinolog. 2010;151:4776–4786. doi:10.1210/en.2009-1349
   PubMed Web of Science ®Google Scholar
• Cichoz-Lach H, Celinski K, Konturek PC, Konturek SJ, Slomka M. The effects of L-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis. J Physiol Pharmacol. 2010;61(5):577–580.
   PubMed Web of Science ®Google Scholar
• Nassir F, Ibdah JA. Role of mitochondria in nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15:8713–8742. doi:10.3390/ijms15058713
   PubMed Web of Science ®Google Scholar
• Staňková P, Kučera O, Peterová E, et al. Western diet decreases the liver mitochondrial oxidative flux of succinate: insight from a murine NAFLD model. Int J Mol Sci. 2021;22(13):6908. doi:10.3390/ijms22136908
   PubMed Web of Science ®Google Scholar
• Rutter J, Winge DR, Schiffman JD. Succinate dehydrogenase - assembly, regulation and role in human disease. Mitochondrion. 2010;10(4):393–401. doi:10.1016/j.mito.2010.03.001
   PubMed Web of Science ®Google Scholar
• van Schaftingen E, Gerin I. The glucose-6-phosphatase system. Biochem J. 2002;362(Pt 3):513–532. doi:10.1042/0264-6021:3620513
   PubMedGoogle Scholar
• Nayak BN, Buttar HS. Evaluation of the antioxidant properties of tryptophan and its metabolites in in vitro assay. J Complement Integr Med. 2016;13(2):129–136. doi:10.1515/jcim-2015-0051
   PubMedGoogle Scholar
• Zhao F, Liu ZQ, Wu D. Antioxidative effect of melatonin on DNA and erythrocytes against free-radical-induced oxidation. Chem Phys Lipids. 2008;151:77–84. doi:10.1016/j.chemphyslip.2007.10.002
   PubMed Web of Science ®Google Scholar
• Dehghan M, Merchant AT. Is bioelectrical impedance accurate for use in large epidemiological studies? Nutr J. 2008;7:26. doi:10.1186/1475-2891-7-26
   PubMed Web of Science ®Google Scholar
• Choi JW, Yoo JJ, Kim SG, Kim YS. Bioelectrical impedance analysis can be an effective tool for screening fatty liver in patients with suspected liver disease. Healthcare. 2022;10(11):2268. doi:10.3390/healthcare10112268
   Web of Science ®Google Scholar
• Schloerb PR, Forster J, Delcore R, Kindscher JD. Bioelectrical impedance in the clinical evaluation of liver disease. Am J Clin Nutr. 1996;64(3):510S–514S. doi:10.1093/ajcn/64.3.510S
   PubMed Web of Science ®Google Scholar